Project Grant HT94252310954
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$250K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Elmore, OH 43416, USA
Similar Awards
This federal Project Grant award of $841,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research performed by Exponent Inc. to assess mortality risk from exposure to the environmental contaminant beryllium and investigate associated co-morbidities. The award, effective September 30, 2023 through September 29, 2026, will fund Exponent's multi-year research project focused on exposure assessment and analysis of the health impacts...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $787,890 project grant to The Research Foundation For The State University Of New York (Stony Brook University) to conduct a 3-year study on "MORTALITY RISK FROM EXPOSURE TO BERYLLIUM: EXPOSURE ASSESSMENT AND CO-MORBIDITIES". This grant supports research efforts to investigate the mortality risks associated with beryllium exposure, including assessing exposure levels and...
The Defense Health Agency awarded a $781,300.00 Project Grant titled "RELATIONSHIP OF METAL EXPOSURES TO HEALTH RISK MARKERS, MOOD, AND COGNITIVE FUNCTIONING IN MILITARY VETERANS" to Trustees of Boston University Medical Campus. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate the relationship between metal exposures, health risk indicators, mood, and cognitive functioning in military veterans....
The federal Project Grant award of $1,715,075.00 was provided by the Defense Health Agency to Beth Israel Deaconess Medical Center, Inc. (Bidmc) under the Military Medical Research and Development (CFDA 12.420) program. The funding supports research on "The Role of TBI Derived DAMPS in Bacterial Pneumonia" over a period from September 30, 2023 to September 29, 2026. As a major academic medical center and teaching hospital, Bidmc has an extensive portfolio of federal grants and...
The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...
The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research.
As part of the...
The federal Project Grant award, ID HT94252510041, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $582,000 grant was awarded on February 15, 2025 to Nushores Biosciences LLC, a for-profit limited liability company located in Little Rock, Arkansas, to develop an "Electrolysis Assisted Catalytic Oxygen Gas Generator for Battlefield Use". The award has an ultimate completion date of August 14, 2026. The Military...
The Defense Health Agency awarded a $1,412,826 Project Grant on September 1, 2023 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Identification of Risk and Early Detection Biomarkers for Liver Cancer," will support a 3-year study led by Dr. Towia Libermann at Bidmc, with a sub-award to Vanderbilt University Medical Center (VUMC) to assist with case...
The U.S. Defense Health Agency awarded Boston Medical Center Corporation, doing business as BMC, a $3,499,453 project grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support the development of novel therapeutics for nephrotic syndrome, with an award period from September 15, 2023 to September 14, 2027. As a leading academic medical center and past recipient of federal research grants and contracts, BMC will leverage its...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award...